NCT00375284 - A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS | Biotech Hunter

Enrollment

404

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2007

Conditions

Restless Legs Syndrome

Interventions

DRUG

Pramipexole

Trial Locations (52)

Unknown

248.616.065 Boehringer Ingelheim Investigational Site, Birmingham

248.616.028 Boehringer Ingelheim Investigational Site, Dothan

248.616.035 Boehringer Ingelheim Investigational Site, Mesa

248.616.025 Boehringer Ingelheim Investigational Site, Peoria

248.616.073 Boehringer Ingelheim Investigational Site, Phoenix

248.616.067 Boehringer Ingelheim Investigational Site, Tucson

248.616.009 Boehringer Ingelheim Investigational Site, Fayetteville

248.616.040 Boehringer Ingelheim Investigational Site, Foothill Ranch

248.616.062 Boehringer Ingelheim Investigational Site, Fullerton

248.616.050 Boehringer Ingelheim Investigational Site, Pasadena

248.616.031 Boehringer Ingelheim Investigational Site, Colorado Springs

248.616.017 Boehringer Ingelheim Investigational Site, Pueblo

248.616.071 Boehringer Ingelheim Investigational Site, Wallingford

248.616.043 Boehringer Ingelheim Investigational Site, DeLand

248.616.014 Boehringer Ingelheim Investigational Site, Jacksonville

248.616.020 Boehringer Ingelheim Investigational Site, Naples

248.616.048 Boehringer Ingelheim Investigational Site, Pembroke Pines

248.616.072 Boehringer Ingelheim Investigational Site, Spring Hill

248.616.018 Boehringer Ingelheim Investigational Site, St. Petersburg

248.616.049 Boehringer Ingelheim Investigational Site, Augusta

248.616.033 Boehringer Ingelheim Investigational Site, Columbus

248.616.057 Boehringer Ingelheim Investigational Site, Macon

248.616.066 Boehringer Ingelheim Investigational Site, Savannah

248.616.047 Boehringer Ingelheim Investigational Site, Stockbridge

248.616.059 Boehringer Ingelheim Investigational Site, Chicago

248.616.045 Boehringer Ingelheim Investigational Site, Lenexa

248.616.061 Boehringer Ingelheim Investigational Site, Olathe

248.616.060 Boehringer Ingelheim Investigational Site, Baton Rouge

248.616.058 Boehringer Ingelheim Investigational Site, Brighton

248.616.051 Boehringer Ingelheim Investigational Site, Wellesley Hills

248.616.001 Boehringer Ingelheim Investigational Site, Minneapolis

248.616.004 Boehringer Ingelheim Investigational Site, Jackson

248.616.064 Boehringer Ingelheim Investigational Site, Florissant

248.616.016 Boehringer Ingelheim Investigational Site, St Louis

248.616.063 Boehringer Ingelheim Investigational Site, St Louis

248.616.053 Boehringer Ingelheim Investigational Site, Dover

248.616.036 Boehringer Ingelheim Investigational Site, Albuquerque

248.616.021 Boehringer Ingelheim Investigational Site, Albany

248.616.013 Boehringer Ingelheim Investigational Site, Cincinnati

248.616.003 Boehringer Ingelheim Investigational Site, Cleveland

248.616.068 Boehringer Ingelheim Investigational Site, Marion

248.616.012 Boehringer Ingelheim Investigational Site, Norman

248.616.006 Boehringer Ingelheim Investigational Site, Oklahoma City

248.616.019 Boehringer Ingelheim Investigational Site, Oklahoma City

248.616.069 Boehringer Ingelheim Investigational Site, Clarks Summit

248.616.008 Boehringer Ingelheim Investigational Site, Columbia

248.616.005 Boehringer Ingelheim Investigational Site, Dallas

248.616.070 Boehringer Ingelheim Investigational Site, Rockwall

248.616.039 Boehringer Ingelheim Investigational Site, San Marcos

248.616.011 Boehringer Ingelheim Investigational Site, Alexandria

248.616.055 Boehringer Ingelheim Investigational Site, Norfolk

248.616.024 Boehringer Ingelheim Investigational Site, Milwaukee